Celgene Corporation CELG is scheduled to report fourth-quarter 2016 results on Jan 26, before the opening bell. Last quarter, the company reported a positive earnings surprise of 6.11%. Notably, shares of Celgene have …
Celgene
Several firms have issued research on Celgene Corporation. They set an "outperform" rating and a $141.00 target price for the company. Analyst research plays a key role on the stock prices.Celgene Corporation was …
Celgene Corporation
A mic drop at the end of Celgene (NASDAQ: CELG) CEO Mark Alles' presentation at the 35th Annual J.P. Morgan (NYSE: JPM) Healthcare …
Celgene
Celgene Corporation (NASDAQ:CELG) — This biotechnology company, which develops and markets small-molecule drugs for the treatment of cancers and inflammatory diseases, was last reviewed on Sept. 20. I …
Celgene Corporation
Finally, Mizuho assumed coverage on Celgene Corporation in a research report on Monday, November 7th. Over the one year trading period, the …
Celgene Corporation